According to FOX News, the FDA just approved Merck & Company’s once-daily treatment for the liver destroying hepatitis C virus. The drug is called Zepatier and it comes two years after Gilead Sciences‘ ground breaking hep C drug Sovaldi. Senior Columnist of thestreet.com, Adam Feuerstein speculates this introduction of Zepatier to the market could produce a price war […]